ReviewJournal of medicine and life2026
Management of obstetric and gynecologic hemorrhage: a narrative review of current guidelines and evidence.
Review in Journal of medicine and life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstetric hemorrhage remains one of the leading causes of maternal morbidity and mortality worldwide despite clinical guidelines and effective interventions. Postpartum hemorrhage is the most common and clinically significant form, yet variability persists across guidelines regarding diagnostic criteria, blood-loss assessment, transfusion thresholds, and escalation strategies. In parallel, gynecologic hemorrhage, particularly acute abnormal uterine bleeding, remains an important cause of morbidity and requires a distinct therapeutic approach. This study was conducted as a structured narrative review informed by systematic search principles. A literature search was performed in PubMed, Scopus, and Web of Science for studies published between January 2020 and January 2026, supplemented by targeted searches of guideline repositories and official organizational websites. The review focused on international guidelines and relevant studies on diagnosis, treatment, transfusion practices, and escalation pathways for obstetric and gynecologic hemorrhage. Of 1,248 records identified, 32 studies were included in the final synthesis. Strong convergence was observed regarding early recognition and administration of uterotonics, particularly oxytocin, as first-line therapy, with early use of tranexamic acid as an adjunct within three hours of birth. Increasing evidence supports protocol-driven care over traditional stepwise escalation. Restrictive transfusion strategies are recommended for stable patients, while clinical status remains the primary determinant in patients with active bleeding. Acute abnormal uterine bleeding management relies on antifibrinolytic and hormonal therapy. Contemporary hemorrhage management is increasingly early, physiology-based, multidisciplinary, and protocolized. Optimal outcomes depend on rapid recognition, prompt first-line treatment, and timely escalation. Integrating principles from gynecologic hemorrhage may further strengthen individualized and etiology-driven care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.